# Adjuvant TACE to Reduce the HCC Recurrence After Resection

> **NCT02788526** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 180 (actual)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **PROCEDURE:** Adjuvant TACE
- **PROCEDURE:** Follow-up

## Key facts

- **NCT ID:** NCT02788526
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-06
- **Final completion:** 2015-06
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2016-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02788526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02788526, "Adjuvant TACE to Reduce the HCC Recurrence After Resection". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02788526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*